Charles Schwab
IMNM icon

Charles Schwab’s Immunome IMNM Stock Holding History

Charles Schwab’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6M Buy
851,789
+11,100
+1% +$247K ﹤0.01% 1783
2025
Q4 		$18.1M Buy
840,689
+177,077
+27% +$3.11M ﹤0.01% 1814
2025
Q3 		$7.77M Buy
663,612
+23,363
+4% +$232K ﹤0.01% 2229
2025
Q2 		$5.95M Buy
640,249
+25,862
+4% +$212K ﹤0.01% 2257
2025
Q1 		$4.13M Buy
614,387
+157,135
+34% +$1.51M ﹤0.01% 2347
2024
Q4 		$4.86M Buy
457,252
+14,775
+3% +$179K ﹤0.01% 2347
2024
Q3 		$6.47M Buy
442,477
+302,916
+217% +$4.3M ﹤0.01% 2242
2024
Q2 		$1.69M Buy
139,561
+121,585
+676% +$1.9M ﹤0.01% 2756
2024
Q1 		$444K Buy
+17,976
New +$365K ﹤0.01% 3074

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return